Results
|
8821.
|
|
|
8822.
|
|
|
8823.
|
|
|
8824.
|
|
|
8825.
|
A mixture model approach in gene-gene and gene-environmental interactions for binary phenotypes. [electronic resource] by
- Li, Lang
- Yu, Menggang
- Jason, Robarge D
- Shen, Changyu
- Azzouz, Faouzi
- McLeod, Howard L
- Borges-Gonzales, Silvana
- Nguyen, Anne
- Skaar, Todd
- Desta, Zeruesenay
- Sweeney, Christopher J
- Flockhart, David A
Producer: 20090122
In:
Journal of biopharmaceutical statistics vol. 18
Availability: No items available.
|
|
8826.
|
|
|
8827.
|
|
|
8828.
|
|
|
8829.
|
ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21. [electronic resource] by
- Geng, Hao
- Rademacher, Brooks L
- Pittsenbarger, Janet
- Huang, Chung-Ying
- Harvey, Christopher T
- Lafortune, Marie C
- Myrthue, Anne
- Garzotto, Mark
- Nelson, Peter S
- Beer, Tomasz M
- Qian, David Z
Producer: 20100428
In:
Cancer research vol. 70
Availability: No items available.
|
|
8830.
|
Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells. [electronic resource] by
- Zhong, Bin
- Sallman, David A
- Gilvary, Danielle L
- Pernazza, Daniele
- Sahakian, Eva
- Fritz, Dillon
- Cheng, Jin Q
- Trougakos, Ioannis
- Wei, Sheng
- Djeu, Julie Y
Producer: 20100916
In:
Molecular cancer therapeutics vol. 9
Availability: No items available.
|
|
8831.
|
|
|
8832.
|
Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer. [electronic resource] by
- Nieto, Yago
- Aramendía, José Manuel
- Espinós, Jaime
- De la Cruz, Susana
- Fernández-Hidalgo, Oscar
- Santisteban, Marta
- Arbea, Leyre
- Aristu, Javier
- Martínez-Monge, Rafael
- Moreno, Marta
- Pina, Luis
- Sola, Josu
- Zornoza, Gerardo
- Regueira, Fernando Martínez
Producer: 20100201
In:
Cancer chemotherapy and pharmacology vol. 65
Availability: No items available.
|
|
8833.
|
|
|
8834.
|
|
|
8835.
|
Normal serum CA125 half-life and normal serum nadir CA125 level in patients with ovarian cancers. [electronic resource] by
- Yoshikawa, T
- Takano, M
- Kita, T
- Kudoh, K
- Sasaki, N
- Kato, M
- Watanabe, A
- Miyamoto, M
- Goto, T
- Furuya, K
Producer: 20121023
In:
European journal of gynaecological oncology vol. 33
Availability: No items available.
|
|
8836.
|
|
|
8837.
|
|
|
8838.
|
|
|
8839.
|
|
|
8840.
|
|